These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 5872509)

  • 1. [Favourable response of advanced ovarian cancer to treatment with a podophyllin derivative (SP-I and SP-G)].
    Tomin R
    Srp Arh Celok Lek; 1965 Oct; 93(10):973-9. PubMed ID: 5872509
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of malignant tumors with SP-I/SP-G Sandoz (Proresid)].
    Bîrzu I
    Ther Umsch; 1966 Dec; 23(12):522-7. PubMed ID: 5980440
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of SPI, SPG and combination of radiotherapy in the management of certain tumors].
    Uzel R; Adali I; Civelekoğlu E
    Turk Tip Cemiy Mecm; 1967 Feb; 33(2):106-16. PubMed ID: 6040938
    [No Abstract]   [Full Text] [Related]  

  • 4. [5-year results of combined treatment with the cobalt bomb and the cytostatic preparation SP-G and SP-I (Sandoz)].
    Hubacher O
    Dtsch Med Wochenschr; 1965 Nov; 90(48):2145-9. PubMed ID: 5844793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibilities of drug therapy of gynecologic malignancies].
    Armborst V
    Med Welt; 1967 Oct; 42():2498-501. PubMed ID: 4306391
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with SP-I].
    Furue H; Koizumi H; Nishi I; Hattori T; Yokoyama T
    Gan No Rinsho; 1967 Sep; 13(9):658-62. PubMed ID: 5627165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical use of podophyllinic acid ethylhydrazide (SP-I) and podophyllotoxin-beta-o-benzyliden-glucoside (SP-G) in malignant urologic tumors].
    Aso Y; Hoshi Y; Okada K; Koiso K; Murahashi I
    Gan No Rinsho; 1969 May; 15(5):453-7. PubMed ID: 5387577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors].
    Ohara H; Noto J; Kihara A; Noguchi H; Ishii Y
    Gan No Rinsho; 1968 Feb; 14(2):96-100. PubMed ID: 5244790
    [No Abstract]   [Full Text] [Related]  

  • 9. [Apropos of a case of carcinoma of the ovary].
    Clerc JP
    Gynaecologia; 1968; 165(2):77-8. PubMed ID: 5703823
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)].
    Lipozencić M; Padovan I
    Rad Med Fak Zagrebu; 1965; 13(1):57-67. PubMed ID: 5871944
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies with Proresid (SP-I) in various transplantable tumors].
    Cerletti A; Stähelin H; Schoch J
    Med Klin; 1966 Jul; 61(30):1192-4. PubMed ID: 5993141
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effects of podophyllin derivatives on malignant neoplasms].
    Diefenthaeler E; Herter NT
    Hospital (Rio J); 1968 Jan; 73(1):183-95. PubMed ID: 5308491
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical observations and results of the treatment of malignant tumors with podophyllim derivatives Sp-I and Sp-G].
    Tomov V; Popov G; Stoianov E
    Khirurgiia (Sofiia); 1965; 18(6):623-32. PubMed ID: 5886870
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of juvenile papilloma of the larynx with resin of podophyllin.
    Fabritius HF
    Acta Otolaryngol; 1966 Jun; ():Suppl 224:467+. PubMed ID: 5992700
    [No Abstract]   [Full Text] [Related]  

  • 15. SPI and SPG in the treatment of advanced malignant lesions.
    Grewal TS; Samual KC; Sachdev DL; Rastogi DC
    Int Surg; 1967 Oct; 48(4):360-7. PubMed ID: 6050546
    [No Abstract]   [Full Text] [Related]  

  • 16. [The association of podophyllum derivatives and cyclophosphamide in the palliative therapy of female pelvic neoplasms].
    Varianti G
    Cancro; 1965; 18(6):526-41. PubMed ID: 4162232
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical use of podophyllin derivatives SP-I and SP-G in the treatment of cancer].
    Kitagawa S; Nishimura K; Motoyama Y; Teramura Y; Hironaka T
    Gan No Rinsho; 1968 Dec; 14(12):1057-61. PubMed ID: 5752852
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience in the therapeutic use of podophyllin in some dermatoses].
    Popov IS; Chepyzhenko VV
    Vrach Delo; 1966 Jan; 1():150-1. PubMed ID: 5974047
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis].
    Szántó L
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:154. PubMed ID: 5402573
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on the treatment of lung cancer with a podophyllum derivative (SP-1)].
    Tansini G; Corti M; Gandini D; Zacco R
    G Ital Chemioter; 1965; 12(1):46-66. PubMed ID: 5881986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.